Covid-19 Update:
- Ensuring the quality, safety and reliable supply of our products is critical to our goal of becoming one of the world’s most innovative, best performing and trusted healthcare companies. We strive for supply excellence, to meet the needs of patients and consumers
- We have supply chain planning in place for all our products, which includes measures to secure reliable supply, such as holding strategic stock and dual sourcing.
- As this is a dynamic situation, we are continuing to monitor closely and provide updates if there is any change
- Our global issue management team (IMT) is assessing the business impact of coronavirus and supporting country IMTs to manage the situation locally. Our initial assessment includes finished goods, Active Pharmaceutical Ingredients (APIs), potential supply responses and distribution routes. We’re conducting ongoing analysis of potential impact and mitigations